Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 37,811 | 2,020 |
| Marketable Securities | 164,869 | 7,130 |
| Receivables | 2,815 | 3,390 |
| Other current assets | 0 | 80 |
| TOTAL | $206,032 | $12,620 |
| Non-Current Assets | ||
| PPE Net | 14,477 | 9,380 |
| Other Non-Current Assets | 184 | 280 |
| TOTAL | $14,661 | $9,660 |
| Total Assets | $220,693 | $22,290 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 1,012 | 870 |
| Accounts payable and accrued liabilities | 2,523 | 1,190 |
| Accrued Expenses | 3,024 | 0 |
| Other current liabilities | N/A | 8,210 |
| TOTAL | $11,231 | $10,600 |
| Non-Current Liabilities | ||
| Long Term Debt | 1,834 | 3,570 |
| Deferred Revenues | 4,672 | N/A |
| TOTAL | $1,834 | $3,576 |
| Total Liabilities | $13,065 | $14,180 |
| Shareholders' Equity | ||
| Common Shares | 48 | 20 |
| Retained earnings | -54,903 | -28,900 |
| Other shareholders' equity | -33,637 | 29,130 |
| TOTAL | $207,628 | $8,110 |
| Total Liabilities And Equity | $220,693 | $22,290 |